Rapport Therapeutics, Inc. Cash Flow Statement

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2023 Dec2024
Operating Activities
Net Income -34.79M-78.31M
Depreciation and Depletion 0.10M0.80M
Share-based Compensation 3.52M10.23M
Gains from Investment Securities 2.29M
Cash from Operations -27.18M-64.83M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.21M3.21M
Depreciation & Amortization (CF) 0.11M0.84M
Change in Working Capital
Change in Account Payables 0.86M-0.35M
Change in Accured Expenses 5.38M0.37M
Investing Activities
Capital Expenditures 1.64M2.40M
Change in Acquisitions & Divestments 209.80M
Cash from Investing Activities -78.86M-170.14M
Financing Activities
Other financing activities 0.13M
Change in Capital Stock
Shares Issued 0.05M157.71M
Preferred Shares Issued 85.30M63.91M
Misc.
Cash from Financing Activities 145.14M221.62M
Change in Cash 39.09M-13.34M
Free Cash Flow -28.82M-67.23M
Net Cash Flow 39.09M-13.34M